Immediate Impact
2 by Nobel laureates 7 from Science/Nature 59 standout
Citing Papers
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
2023 Standout
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023 Standout
Works of Yvette Taché being referenced
Synergistic interaction between CCK and leptin to regulate food intake
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Yvette Taché | 274 | 164 | 156 | 166 | 164 | 7 | 598 | |
| E. E. Ladenheim | 371 | 183 | 371 | 173 | 32 | 16 | 684 | |
| F. Holly Coleman | 281 | 134 | 104 | 65 | 31 | 20 | 591 | |
| Timothy H. Moran | 264 | 86 | 255 | 182 | 26 | 10 | 612 | |
| Erica L. Huey | 332 | 149 | 136 | 209 | 18 | 7 | 725 | |
| Jessica Kimmel | 120 | 82 | 41 | 188 | 36 | 13 | 692 | |
| Maria Hamze Sinno | 232 | 145 | 31 | 166 | 36 | 16 | 512 | |
| Ahmed M. Hassan | 63 | 33 | 68 | 201 | 138 | 16 | 618 | |
| Ted D. Hoyda | 372 | 107 | 134 | 242 | 45 | 11 | 681 | |
| EM Stricker | 176 | 67 | 70 | 185 | 73 | 9 | 592 | |
| Ying C. Lee | 260 | 62 | 429 | 61 | 26 | 8 | 594 |
All Works
Loading papers...